Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 62351-62400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT03571568
A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL
PHASE1/PHASE2
Recruiting
140 participants
Started: May 16, 2018 · Completed: Sep 30, 2026
1 condition
1 sponsor
27 locations
NCT03510208
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
PHASE1/PHASE2
Recruiting
46 participants
Started: May 16, 2018 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT03467516
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
PHASE2
Recruiting
47 participants
Started: May 14, 2018 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03579836
Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer
PHASE1/PHASE2
Recruiting
75 participants
Started: May 14, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03482102
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
PHASE2
Recruiting
70 participants
Started: May 14, 2018 · Completed: Oct 31, 2026
2 conditions
2 sponsors
2 locations
NCT03126916
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
PHASE3
Recruiting
750 participants
Started: May 14, 2018 · Completed: Sep 30, 2030
3 conditions
2 sponsors
161 locations
NCT03354728
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
PHASE1/PHASE2
Recruiting
80 participants
Started: May 11, 2018 · Completed: Dec 11, 2026
2 conditions
2 sponsors
1 location
NCT03855800
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
NA
Recruiting
800 participants
Started: May 11, 2018 · Completed: Dec 30, 2030
1 condition
2 sponsors
1 location
NCT04206852
Safety and Efficacy of Balloon Pulmonary Angioplasty in China
N/A
Recruiting
200 participants
Started: May 11, 2018 · Completed: May 11, 2028
1 condition
1 sponsor
2 locations
NCT04074720
Prospective Breast Cancer Biospecimen Collection
NA
Recruiting
200 participants
Started: May 10, 2018 · Completed: Jul 1, 2028
3 conditions
1 sponsor
1 location
NCT03646708
Response Assessment in SB CD
N/A
Recruiting
200 participants
Started: May 9, 2018 · Completed: May 30, 2026
1 condition
2 sponsors
1 location
NCT03258580
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
NA
Recruiting
700 participants
Started: May 9, 2018 · Completed: May 30, 2027
3 conditions
1 sponsor
1 location
NCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
NA
Recruiting
472 participants
Started: May 9, 2018 · Completed: May 9, 2027
7 conditions
1 sponsor
1 location
NCT06068075
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma As a Prognostic and Response Diagnostic: LEOPARD
NA
Recruiting
340 participants
Started: May 8, 2018 · Completed: Jan 1, 2026
7 conditions
5 sponsors
15 locations
NCT03321201
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery
NA
Recruiting
164 participants
Started: May 8, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03377517
Radiosurgical Hypophysectomy for Bone Metasteses Pain
NA
Recruiting
16 participants
Started: May 8, 2018 · Completed: Dec 31, 2030
1 condition
2 sponsors
1 location
NCT02359812
Robot Aided Rehabilitation - Multi-joint Evaluations
N/A
Recruiting
56 participants
Started: May 7, 2018 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT03609580
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
PHASE1/PHASE2
Recruiting
127 participants
Started: May 7, 2018 · Completed: Mar 30, 2026
1 condition
1 sponsor
1 location
NCT03090165
Ribociclib and Bicalutamide in AR+ TNBC
PHASE1/PHASE2
Recruiting
37 participants
Started: May 7, 2018 · Completed: Sep 30, 2025
1 condition
4 sponsors
6 locations
NCT03546387
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
N/A
Recruiting
75 participants
Started: May 7, 2018 · Completed: May 7, 2026
2 conditions
1 sponsor
1 location
NCT03525769
Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes
N/A
Recruiting
10,000 participants
Started: May 5, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03291444
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
PHASE1
Recruiting
30 participants
Started: May 5, 2018 · Completed: Jun 1, 2025
3 conditions
3 sponsors
1 location
NCT03657693
MRI in BPD Subjects
N/A
Recruiting
160 participants
Started: May 4, 2018 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
PHASE1/PHASE2
Recruiting
747 participants
Started: May 4, 2018 · Completed: Dec 31, 2025
15 conditions
3 sponsors
7 locations
NCT03525002
Dopamine Action on Metabolism in Relation to Genotype
PHASE2
Recruiting
150 participants
Started: May 3, 2018 · Completed: Jun 30, 2025
1 condition
3 sponsors
3 locations
NCT03670524
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
NA
Recruiting
835 participants
Started: May 3, 2018 · Completed: Oct 30, 2026
2 conditions
3 sponsors
1 location
NCT03295981
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
PHASE3
Recruiting
120 participants
Started: May 3, 2018 · Completed: Jan 31, 2028
1 condition
18 sponsors
16 locations
NCT03025256
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
PHASE1
Recruiting
70 participants
Started: May 2, 2018 · Completed: Dec 30, 2025
10 conditions
2 sponsors
1 location
NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
523 participants
Started: May 2, 2018 · Completed: Nov 30, 2027
8 conditions
1 sponsor
45 locations
NCT03108196
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
NA
Recruiting
96 participants
Started: May 2, 2018 · Completed: Sep 30, 2025
2 conditions
5 sponsors
1 location
NCT02874599
Cohort Biomonitoring Study to Evaluate the Biocompatibilty of Resin-based Dental Materials
NA
Recruiting
100 participants
Started: May 2, 2018 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT03460522
Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL
PHASE2
Recruiting
65 participants
Started: May 2, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
14 locations
NCT03507673
Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction
N/A
Recruiting
1,200 participants
Started: May 2, 2018 · Completed: Jun 30, 2028
1 condition
1 sponsor
5 locations
NCT05449522
Vitamin D for Critically Traumatic Patients
NA
Recruiting
100 participants
Started: May 1, 2018 · Completed: Jul 1, 2026
2 conditions
1 sponsor
1 location
NCT03310905
Abdominal Wall Transplant
NA
Recruiting
5 participants
Started: May 1, 2018 · Completed: Jun 1, 2028
7 conditions
4 sponsors
1 location
NCT03893734
Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery
PHASE4
Recruiting
140 participants
Started: May 1, 2018 · Completed: Dec 23, 2020
1 condition
1 sponsor
1 location
NCT03465592
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
PHASE1/PHASE2
Recruiting
39 participants
Started: May 1, 2018 · Completed: Mar 31, 2029
3 conditions
2 sponsors
4 locations
NCT06239909
Adjustable Artificial Sphincter Victo in the Treatment of Male Incontinence Due to Prostate Surgery
N/A
Recruiting
150 participants
Started: May 1, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03965988
Docosahexaenoic Acid on Breath Holding Spells in Children
PHASE3
Recruiting
60 participants
Started: May 1, 2018 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03504800
OCT in Diagnosis of Irregular Corneas
N/A
Recruiting
445 participants
Started: May 1, 2018 · Completed: Feb 28, 2031
3 conditions
1 sponsor
1 location
NCT03555903
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort
N/A
Recruiting
500 participants
Started: May 1, 2018 · Completed: Feb 29, 2028
1 condition
1 sponsor
1 location
NCT05242393
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)
N/A
Recruiting
250 participants
Started: May 1, 2018 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03587922
FANTOM Post Market Clinical Trial
NA
Recruiting
1,500 participants
Started: May 1, 2018 · Completed: May 1, 2025
1 condition
1 sponsor
10 locations
NCT03368313
Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis
NA
Recruiting
120 participants
Started: May 1, 2018 · Completed: Nov 30, 2025
2 conditions
1 sponsor
18 locations
NCT03346694
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
NA
Recruiting
660 participants
Started: May 1, 2018 · Completed: May 1, 2035
1 condition
1 sponsor
1 location
NCT03860558
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
NA
Recruiting
40 participants
Started: May 1, 2018 · Completed: Jul 1, 2025
3 conditions
1 sponsor
1 location
NCT05764434
ALS Spinal Cord Gray and White Matter Study
N/A
Recruiting
80 participants
Started: May 1, 2018 · Completed: Oct 1, 2025
1 condition
1 sponsor
1 location
NCT03860857
Biomarker Exploration in Aging, Cognition and Neurodegeneration
PHASE3
Recruiting
300 participants
Started: May 1, 2018 · Completed: Dec 22, 2027
3 conditions
2 sponsors
1 location
NCT03337932
Duration of Doxycycline Treatment in MEM Patients
NA
Recruiting
200 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04263298
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
PHASE3
Recruiting
210 participants
Started: May 1, 2018 · Completed: May 1, 2030
1 condition
1 sponsor
13 locations
Previous
1
More pages
1245
1246
1247
1248
1249
1250
1251
More pages
1333
Next